Medical/Pharmaceuticals
Samsung Biologics hosts ESG event with suppliers to strengthen decarbonization efforts
INCHEON, South Korea, Dec. 3, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today hosted its second Supplier ESG Day to share insights on sustainable management and encourage ESGactions among suppliers. Second of i...
2024-12-03 20:00
2036
Fangzhou Inc. Announces Inclusion of Its Shares in Hang Seng Hong Kong-Listed Biotech Index
HONG KONG, Dec. 3, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced today that the Company's Ordinary Shares, which trade on The Stock Exchange of Hong Kong Limited ("HKEX"), will be included in the Hang Seng Hong Ko...
2024-12-03 18:47
2013
InventisBio Announces Positive Phase 2 Study Results for D-2570 (TYK2 Inhibitor) in Patients with Moderate to Severe Plaque Psoriasis
– D-2570 demonstrates robust efficacy and favorable safety profile, achieving skin clearance comparable to leading biologics – SHANGHAI, Dec. 3, 2024 /PRNewswire/ -- InventisBio Co., Ltd. today announced promising results from a Phase 2 clinical trial of D-2570, an oral selective inhibitor of th...
2024-12-03 17:44
1904
HKBU scientist's Automated Multiplex Diagnostics System recommended by WHO as an innovative health technology for low-resource contexts
HONG KONG, Dec. 3, 2024 /PRNewswire/ -- The Automated Multiplex Diagnostics System developed by Professor Terence Lau, Interim Chief Innovation Officer of Hong KongBaptist University (HKBU), has been recommended in the 2024 Compendium of Innovative Health Technologies for Low-resource Settings pu...
2024-12-03 15:03
2087
Beijing Review: Love Without Barriers
BEIJING, Dec. 3, 2024 /PRNewswire/ -- Meide Yanyuan, a courtyard in Beijing's Changping District, is a studio for those seeking prosthetics and orthotics. Here, under the care ofGeorg Hoffmann-Kuhnt, a German prosthetist and orthotist, bodies and lives are given new strength. Many of its visitors...
2024-12-03 14:27
1872
Datasea Hosts Product Promotion Event and Signs Sales Agreement for up to 300,000 High-Tech Acoustic Units
The agreement is expected to generate up to approximately $20.8 million annually BEIJING, Dec. 2, 2024 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), aNevada digital technology company focused on innovations in acoustic high-tech and 5G AI multimodal digital technologie...
2024-12-02 22:45
2685
United Imaging Debuts Breakthrough AI-Powered Innovations at RSNA 2024
HOUSTON, Dec. 2, 2024 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will showcase a range of cutting-edge technologies at RSNA 2024. This year's exhibit will include several new product debuts in the fields of magnetic resona...
2024-12-02 22:00
2021
ACROBiosystems' US Innovation Lab Earns ISO 17025 Accreditation to Accelerate Biomedicine Discovery and Development
NEWARK, Del., Dec. 2, 2024 /PRNewswire/ -- ACROBiosystems' US Innovation Lab has recently achieved ISO/IEC 17025 accreditation for its Surface Plasmon Resonance (SPR) analytical service, ensuring that results from this service is globally recognized and trusted for its precision and consistency. ...
2024-12-02 22:00
2167
MeditWave 2024 in Porto Brings Together Global Experts to Shape the Future of Digital Dental Solutions
PORTO, Portugal, Dec. 2, 2024 /PRNewswire/ -- On November 9, Medit, a global leader in digital dentistry solutions, hosted its two-day MeditWave 2024 in Porto, Portugal. This dynamic gathering of dental professionals from around the world fostered valuable exchanges and showcased the latest innova...
2024-12-02 22:00
1961
Real-World Validation: Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment
Follow-up to ScreenTrustCAD presented at RSNA 2024 highlights 1-year post-AI adoption success in improving cancer detection, radiologist workload, and screening efficiency SEOUL, South Korea, Dec. 2, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cance...
2024-12-02 22:00
2378
Health On Cloud Showcases Innovative Healthcare Solutions at the Korea-LAC Trade and Innovation Forum, Accelerating Expansion into Latin America
SEOUL, South Korea, Dec. 2, 2024 /PRNewswire/ -- Health On Cloud (HOC) is impactingColombia's healthcare sector through the use of digital innovations in a pilot project funded by the Inter-American Development Bank (IDB). This initiative is scheduled to expand toMexico and Brazil in the first ha...
2024-12-02 22:00
2177
Fangzhou Inc. Strengthens Partnerships with Tencent and Baidu, Unveiling its "AI Agent Solution"
CHENGDU, China, Dec. 2, 2024 /PRNewswire/ -- On November 22, 2024, Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, hosted the "Data and AI: Decoding Digital Engagement" summit in Chengdu, bringing together key representatives from leading Internet...
2024-12-02 15:21
2330
MGI Tech announces partnership with Universidad de San Martín de Porres to strengthen human genetics research
* The implementation of MGI Tech's next-generation genomic sequencing (NGS) technologies will strengthen scientific research in the country, enabling the identification of key genetic variations, contributing to disease prevention, and personalizing medical treatments. * A team of specialists...
2024-12-02 11:16
1820
BGM Group Ltd Pioneers Innovation in AI Technology, Fostering Holistic Integration of Healthcare and Insurtech
CHENGDU, China, Nov. 29, 2024 /PRNewswire/ -- BGM Group Ltd. (NASDAQ: BGM) ("the Company" or "BGM"), a leading global pharmaceutical enterprise, today announced its acquisition of the intelligent platform of AIX Inc. (NASDAQ: AIFU) ("AIX") valued at1 billion RMB (approximately $140 million). The ...
2024-11-29 23:58
5988
MicuRx: Successfully Completes Phase III Clinical Trial of MRX-4 for Injection in China
SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of its Phase III clinical trial of MRX-4 for injection transitioning to oral Contezolid tablets for the treatment of adult patients with complex sk...
2024-11-29 22:00
4086
Minghui Pharmaceutical Announces Positive Topline Results from Phase Ⅲ Trial of MH004 (Tofacitinib Etocomil) Ointment in Mild to Moderate Atopic Dermatitis
SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announced positive topline results from its phase Ⅲ trial of MH004 (tofacitinib etocomil) ointment 1.0%, a twic...
2024-11-29 20:31
3712
Akeso to Present at Citi 2024 Global Healthcare Conference and the 7th Annual Evercore HealthCONx Conference
HONG KONG, Nov. 28, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce its participation in the upcoming 7th Annual Evercore HealthCONx Conference and Citi 2024 Global Healthcare Conference, both taking place inMiami. Akeso will participate in a firesid...
2024-11-29 10:23
2008
Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecifi...
2024-11-28 21:06
4375
Akeso Announced the Inclusion in China's National Reimbursement Drug List of Cadonilimab and Ivonescimab
HONG KONG, Nov. 27, 2024 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce that two of its independently developed, globally pioneering bispecific antibody drugs—cadonilimab Injection (PD-1/CTLA-4 bispecific antibody) and ivonescimab Injection (PD-1/VEGF bi...
2024-11-28 11:58
2590
Lunit Inks Partnership with Salud Digna to Advance AI in Medical Imaging
* AI-powered chest X-ray and mammography analysis solutions to be deployed across one ofMexico's largest healthcare networks SEOUL, South Korea, Nov. 27, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announc...
2024-11-27 22:00
2648
Week's Top Stories
Most Reposted
DBS is First Bank in Asia Pacific to Pilot Visa Intelligent Commerce for Everyday Payments
[Picked up by 319 media titles]
2026-02-16 10:00
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 318 media titles]
2026-02-19 14:30
Little Artists Art Studio, Singapore Shines at Art Capital 2026
[Picked up by 277 media titles]
2026-02-17 19:12
Kung Fu Meets Spring -- Unitree Spring Festival Gala Robots Present "Cyber Real Kung Fu" in the Year of the Horse
[Picked up by 256 media titles]
2026-02-17 14:16SMU MBA Rises in FT Global Rankings, Excelling in ESG, Salary and Value-for-Money
[Picked up by 250 media titles]
2026-02-16 08:00Most Read
From Date Night to Game Night: Shop Nework's Special Valentine's Deal to Share the Meaningful Moments and Memories
2026-02-15 01:00
6391
